Personalis (United States)
company in Menlo Park, United States
PSNL Nasdaq
SEC CIK 1527753 LEI 549300EZ2NYFK7H0US48
Follow Personalis (United States)
Weekly email: filings, results
Revenue, last quarter
$25.6M
+76.6% vs same quarter last year
Net income
−$33.8M
−56.1% vs same quarter last year
EPS, diluted
−$0.32
−33.3% vs same quarter last year
Operating cash flow
−$27.1M
−24.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $69.6M | −$81.3M |
| FY24 | $84.6M | −$81.3M |
| FY23 | $73.5M | −$108.3M |
| FY22 | $65M | −$113.3M |
| FY21 | $85.5M | −$65.2M |
| FY20 | $78.6M | −$41.3M |
| FY19 | $65.2M | −$25.1M |
| FY18 | $37.8M | −$19.9M |
| FY17 | $9.4M | −$23.6M |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 22.7% | −126.4% | −116.7% |
| FY24 | 31.7% | −80.7% | −96.1% |
| FY23 | 24.8% | −149.6% | −147.4% |
| FY22 | 20.5% | −177.6% | −174.2% |
| FY21 | 37% | −76.4% | −76.3% |
| FY20 | 25.6% | −53.6% | −52.5% |
| FY19 | 33.9% | −34.4% | −38.5% |
| FY18 | 31.3% | −36.5% | −52.6% |
| FY17 | −24.9% | −236% | −251.2% |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$79.5M |
| FY24 | −$46.8M |
| FY23 | −$67.2M |
| FY22 | −$120.1M |
| FY21 | −$81.9M |
| FY20 | −$45.9M |
| FY19 | −$26.5M |
| FY18 | −$2.3M |
| FY17 | −$4.9M |
| FY16 | - |
- Personalis (United States)
- Healthcare median
Show the numbers
| Year | Personalis (United States) | Healthcare median |
|---|---|---|
| FY25 | −116.7% | −30.6% |
| FY24 | −96.1% | −47% |
| FY23 | −147.4% | −58% |
| FY22 | −174.2% | −80.4% |
| FY21 | −76.3% | −71.8% |
| FY20 | −52.5% | −62.2% |
| FY19 | −38.5% | −46.2% |
| FY18 | −52.6% | −49.6% |
| FY17 | −251.2% | −45.9% |
| FY16 | - | −36% |